PACER: Locally Advanced Pancreatic Cancer: Phase II study of Cetuximab and 3-D Conformal image guided Radiotherapy.

Trial Profile

PACER: Locally Advanced Pancreatic Cancer: Phase II study of Cetuximab and 3-D Conformal image guided Radiotherapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2016

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Acronyms PACER
  • Most Recent Events

    • 29 Jun 2011 Additional lead investigator added as reported United Kingdom Clinical Research Network record.
    • 09 Oct 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
    • 09 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top